NIH Launches Trial of Hydroxychloroquine, Azithromycin for COVID - 19

Trial will enroll 2,000 patients with SARS - COV - 2 who have fever, cough, and/or shortness of breath
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Infections, Internal Medicine, Critical Care, Emergency Medicine, Pharmacy, Pulmonology, Institutional, Source Type: news